Plain-English translation of NCT06572085 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether a medication called butylphthalide can help protect and improve brain function in people who have survived cardiac arrest. Cardiac arrest is a life-threatening emergency where the heart stops beating, and people who survive it often experience serious brain damage. This trial will compare the medication to a placebo (salt water) to see if it can help patients recover better neurological function.
Many cardiac arrest survivors develop severe brain injuries or permanent neurological problems, even after their heart starts beating again. Researchers have seen promising results with this medication in patients with stroke, so they want to test whether it could also help protect the brains of cardiac arrest survivors and improve their long-term recovery.
You likely qualify if…
You likely don't qualify if…
You would receive either the medication or a placebo (salt water) by intravenous infusion twice a day for 14 days following your cardiac arrest. Doctors would assess your brain function and neurological recovery during your hospital stay and at follow-up visits using standard medical scales. The trial involves about 350 participants across multiple hospitals.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China